Ethics approval and consent to participate: Patients’ written consents were obtained according to the Declaration of Helsinki, when they were first entered into the database for treatment. The Ethics Committee’s approval was obtained from all participating centerscentres (approval no. 23943), as well as the written informed consent for the anonymous use of personal data from every patient, in compliance with Italian Legislative Decree 196/2003.
Consent for publication: Not required.
Availability of data and material: Data are available on reasonable request. Please contact the corresponding author: Roberta Ramonda ([email protected]).
Competing of interest: RR has received honoraria and speaker fees from Novartis, Abbvie, Pfizer, MSD, and Janssen. CS has received consulting / speaker fees from AbbVie, Amgen, Alfa-Sigma, Biogen, Eli-Lilly, EUSA Pharma - Recordati, Galapagos, Janssen, Novartis, Octapharma, Pfizer, Recordati Rare Disease, SOBI and research support from AbbVie, Amgen, Janssen, Novartis, Pfizer. AO received consultancy fees from Abbvie, Janssen, Novartis, UCB. AM has received honoraria and speaker fees from Abbvie, Pfizer, MSD, UCB, Novartis, Janssen, and Eli-Lilly. LS has received speaker fees from Jansen, Novartis, Pfizer, UCB, MSD, and Sanofi. AD has received honoraria and speaker fees from Novartis, AbbVie, Pfizer, MSD, Janssen.AC has received speaker fees from Novartis, Abbvie, Eli-Lilly and Janssen.
The other authors declare no potential conflicts of interest with regards to the research, authorship, and/or publication of this article.
Funding: This study was not financially supported by any pharmaceutical company.
Acknowledgments: The authors wish to thank the Italian Society of Rheumatology’s (SIR) “Spondyloarthritis and Psoriatic Arthritis Study Group—A. Spadaro.” The authors would like to thank Welocalize for a native English review of this paper. This support was funded by Novartis Farma.
Contributing authors of the Spondyloarthritis and Psoriatic Arthritis SIR Study Group ‘Antonio Spadaro’: Roberta Foti, MD,Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, Elisa Visalli, MD,Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, Ylenia Dal Bosco, MD,Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, De Lucia Francesco, MD,Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, Cesaro Siracusano, MD, Rheumatology Unit, University of Messina, Messina, Sicilia, Italy, Sergio Collela, MD,Rheumatology Unit, Martina Franca-ASL Taranto, Martina Franca Hospital, Martina Franca, Taranto,Puglia, Italy, Giacomo M Guidelli, MD, PhD, Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Lombardia, Italy, Nicoletta Luciano, MD,Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Lombardia, Italy, Valentino Paci, MD, Department of Clinical and Molecular Sciences, University Hospital of the Marche Region, Ancona, Marche, Italy, Giulia Marchionni, MD, Department of Clinical and Molecular Sciences, University Hospital of the Marche Region, Ancona, Marche, Italy, Nicolò Girolimetto, MD, PhD, Rheumatology Unit, Department of Internal Medicine, Azienda USL-IRCCS, University of Modena and Reggio Emilia, Emilia Romagna, Italy, Alberto Floris, MD, Rheumatology Unit, Department of Medical Sciences, AOU and University of Cagliari, Monserrato, Sardegna, Italy, Giorgia Citriniti, MD, Rheumatology Unit, Department of Internal Medicine, Azienda USL-IRCCS, University of Modena and Reggio Emilia, Emilia Romagna, Italy, Giovanni Striani, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Veneto, Italy.
The members of the “Spondyloartritis and Psoriatic Arthritis Study Group—A. Spadaro” who collaborated to this study are as follows:
Roberta Ramonda, Prof, MD, PhD, Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Veneto, Italy, Maria Sole Chimenti, Prof, MD, PhD, Rheumatology, allergology and clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Lazio, Italy, Fabiola Atzeni, Prof, MD, PhD, MD, Rheumatology Unit, University of Messina, Messina, Sicilia, Italy,Angelo Semeraro, Prof, MD, Rheumatology Unit, Martina Franca-ASL Taranto, Martina Franca Hospital, Martina Franca, Taranto,Puglia, Italy, Salvatore D’Angelo, Prof, MD, PhD, Rheumatology Institute of Lucania (IReL), San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Basilicata, Italy, Carlo Selmi, Prof, MD, PhD,Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Lombardia, Italy, Antonio Marchesoni, Prof, MD, PhD, MD, PhD, Rheumatology, Humanitas San Pio X, Milan, Lombardia, Italy, Maria Manara, MD, PhD, Department of Rheumatology, ASST Gaetano Pini-CTO, Milan, Lombardia, Italy, Michele Maria Luchetti Gentiloni, Prof, MD, PhD, MD, Department of Clinical and Molecular Sciences, University Hospital of the Marche Region, Ancona, Marche, Italy, Leonardo Santo, MD, Rheumatology Unit, ASL BT Andria – DSS4 Barletta, Italy, Barletta-Andria-Trani, Puglia, Italy, Carlo Salvarani, Prof, MD, PhD,Rheumatology Unit, Department of Internal Medicine, Azienda USL-IRCCS, University of Modena and Reggio Emilia, Emilia Romagna, Italy, Alberto Cauli, Prof,MD, PhD, Rheumatology Unit, Department of Medical Sciences, AOU and University of Cagliari, Monserrato, Sardegna, Italy, Maurizio Rossini, Prof, MD, PhD, Rheumatology Unit, Department of Medicine, AOUI University of Verona, Verona, Veneto, Italy, Andrea Doria, Prof, MD, PhD, Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Veneto, Italy, Rosario Foti, Prof, MD, PhD, Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, Antonio Carletto, MD, Rheumatology Unit, Department of Medicine, AOUI University of Verona, Verona, Veneto, Italy, Antonio Carriero, MD, PhD, Rheumatology Institute of Lucania (IReL), San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Basilicata, Italy, Mariagrazia Lorenzin, MD, PhD, Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Veneto, Italy, Giorgio Amato, MD, Prof, MD, PhD, Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, Augusta Ortolan, MD, PhD, Rheumatology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Lazio, Italy, Giacomo Cozzi, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Veneto, Italy, Laura Scagnellato, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Veneto, Italy, Mario Ferraioli, MD, PhD, Rheumatology, allergology and clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Lazio, Italy, Elena Fracassi, MD, Rheumatology Unit, Department of Medicine, AOUI University of Verona, Verona, Veneto, Italy Francesco Giorgio, MD, Rheumatology Unit, Department of Medicine, AOUI University of Verona, Verona, Veneto, Italy, Roberta Foti, MD,Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, Elisa Visalli, MD,Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, Ylenia Dal Bosco, MD,Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, De Lucia Francesco, MD,Rheumatology Unit, A.O.U. Policlinico S. Marco, Catania, Sicilia, Catania, Italy, Cesaro Siracusano, MD, Rheumatology Unit, University of Messina, Messina, Sicilia, Italy, Sergio Collela, MD,Rheumatology Unit, Martina Franca-ASL Taranto, Martina Franca Hospital, Martina Franca, Taranto,Puglia, Italy, Giacomo M Guidelli, MD, PhD, Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Lombardia, Italy, Nicoletta Luciano, MD,Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Lombardia, Italy, Valentino Paci, MD, Department of Clinical and Molecular Sciences, University Hospital of the Marche Region, Ancona, Marche, Italy, Giulia Marchionni, MD, Department of Clinical and Molecular Sciences, University Hospital of the Marche Region, Ancona, Marche, Italy, Nicolò Girolimetto, MD, PhD, Rheumatology Unit, Department of Internal Medicine, Azienda USL-IRCCS, University of Modena and Reggio Emilia, Emilia Romagna, Italy, Alberto Floris, MD, Rheumatology Unit, Department of Medical Sciences, AOU and University of Cagliari, Monserrato, Sardegna, Italy, Giorgia Citriniti, MD, Rheumatology Unit, Department of Internal Medicine, Azienda USL-IRCCS, University of Modena and Reggio Emilia, Emilia Romagna, Italy, Giovanni Striani, MD, Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Veneto, Italy.
Authors’ contributions
RR and AC were responsible for the study conceptualization and design. ML, RR, MSC, FA, AS, SDA, CS, AO, AM, MMLG, LS, CS, AC, MR, GA, GC, LS, MF, AC, EF, FG, AD, RF, AC participated in the selection of patients, in the clinical assessment and the data collection and management. ML performed the statistical analysis. ML and RR interpreted the results and drafted the manuscript. ML, RR, MSC, FA, AS, SDA, CS, AO, AM, MMLG, LS, CS, AC, MR AD, RF, AC reviewed the paper.
All the authors made substantive intellectual contributions to the study, reviewed the article, and gave their final approval to the submitted version.